Advertisement
Advertisement
U.S. Markets open in 7 hrs 20 mins
Advertisement
Advertisement
Advertisement
Advertisement

DWS High Income Fund (KHYAX)

Nasdaq - Nasdaq Delayed Price. Currency in USD
Add to watchlist
4.3500-0.0300 (-0.68%)
At close: 08:01PM EDT
Advertisement
Full screen
Previous Close4.3800
YTD Return-7.35%
Expense Ratio (net)0.00%
CategoryHigh Yield Bond
Last Cap Gain0.00
Morningstar Rating★★★★
Morningstar Risk RatingN/A
Sustainability RatingN/A
Net Assets670.63M
Beta (5Y Monthly)N/A
YieldN/A
5y Average ReturnN/A
Holdings TurnoverN/A
Last Dividend0.02
Average for CategoryN/A
Inception DateJan 26, 1978
  • PR Newswire

    UFC® AND THORNE ANNOUNCE MULTI-YEAR EXTENSION OF PARTNERSHIP

    UFC®, the world's premier mixed martial arts organization, and Thorne Health Tech, Inc. ("Thorne HealthTech" or "Thorne") (NASDAQ: THRN), a leader in developing innovative solutions for a personalized approach to health and wellbeing, today announced a multi-year extension of their global marketing partnership. Thorne remains the Official Sports Performance Nutrition Partner of UFC and an official partner of the UFC Performance Institute®, the world's first Mixed Martial Arts (MMA) multi-discipl

  • CNW Group

    Tetra Bio-Pharma Signs License Agreement with Thorne for a Prebiotic Dietary Supplement

    Tetra Bio-Pharma Inc ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development, today announced it has signed a Licensing Agreement with Thorne Health Tech, Inc. ("Thorne HealthTech" or "Thorne") (NASDAQ: THRN), a leader in developing innovative solutions for a personalized approach to health and wellbeing, for the commercialization of its patent protected prebiotic dietary supplement in the U.S. market. The Agreement will incl

Advertisement
Advertisement